Meihua International Medical Technologies Co., Ltd. (MHUA)
NASDAQ: MHUA · IEX Real-Time Price · USD
0.780
+0.039 (5.23%)
At close: Mar 27, 2024, 4:00 PM
0.800
+0.020 (2.54%)
Pre-market: Mar 28, 2024, 6:10 AM EDT

MHUA Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019
Revenue
103.35104.0489.0679.63
Revenue Growth (YoY)
-0.66%16.82%11.85%-
Cost of Revenue
65.2564.2351.947.42
Gross Profit
38.139.8137.1632.21
Selling, General & Admin
19.5810.8211.29.61
Research & Development
2.962.732.493.21
Other Operating Expenses
4.76000
Operating Expenses
27.313.5413.6912.82
Operating Income
10.826.2623.4719.39
Interest Expense / Income
0.190.180.140.1
Other Expense / Income
-0.35-0.15-0.40.04
Pretax Income
10.9626.2323.7319.25
Income Tax
4.715.284.693.82
Net Income
6.2420.9519.0515.43
Net Income Growth
-70.20%10.00%23.42%-
Shares Outstanding (Basic)
23202019
Shares Outstanding (Diluted)
23202019
Shares Change
17.06%-7.67%-
EPS (Basic)
0.271.050.950.83
EPS (Diluted)
0.271.050.950.83
EPS Growth
-74.29%10.53%14.46%-
Free Cash Flow
-11.84-0.89-10.770.41
Free Cash Flow Per Share
-0.51-0.04-0.540.02
Gross Margin
36.86%38.26%41.72%40.45%
Operating Margin
10.45%25.24%26.35%24.35%
Profit Margin
6.04%20.14%21.38%19.38%
Free Cash Flow Margin
-11.46%-0.85%-12.09%0.51%
Effective Tax Rate
43.02%20.13%19.75%19.84%
EBITDA
11.7127.0324.3919.86
EBITDA Margin
11.34%25.98%27.39%24.94%
Depreciation & Amortization
0.560.620.520.51
EBIT
11.1526.4123.8719.35
EBIT Margin
10.79%25.38%26.80%24.30%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).